|
|
|
 |
|
|
| News & Views |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Top Stories |
|
|
|
|
|
|
|
|
|
|
| Finance Tools |
|
|
|
|
|
|
|
|
|
|
| Search |
|
|
|
|
|
|
About Us
|
|
|
|
|
|
|
|
|
| Other Digital Look Sites |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Day Low/High | 2,786.50p/2,844.62p |
|
|
|
| 52 wk Low/High | 2,147.00p/3,102.50p |
|
|
|
| All prices are delayed by 15 mins |
|
| Price Data |
|
Market Data |
| Change Over |
|
Chg |
%Chg |
| 1 week | | -93.50p | -3.19 |
| 1 month | | -71.00p | -2.44 |
| 1 year | | 250.50p | +9.68 |
|
|
|
|
|
|
|
|
|
|
| Company News | Related Market News |
|
-
Tue 09 Feb 2010
The US Food and Drug Administration has approved the wider use of AstraZeneca's cholesterol-lowering drug Crestor as a preventive measure against heart attacks and strokes.
-
Fri 05 Feb 2010
Morgan Stanley remains a fan of the pharmaceuticals sector and has identified Swiss giant Roche and Anglo-Swedish titan AstraZeneca as its preferred picks.
-
Thu 28 Jan 2010
AstraZeneca posted a 10% rise in fourth quarter earnings, but the drug giant’s shares fell back as it predicted 2010 revenues would be hit by the loss of exclusive rights to sell certain drugs.
-
Wed 27 Jan 2010
AstraZeneca, one of the top ten UK companies by market value, releases fourth quarter and full year results on Thursday, when it will have to deliver on the increased profit expectations it announced at the end of October.
-
Thu 07 Jan 2010
Drugs firm AstraZeneca has come to an agreement with Israel-based rival Teva Pharmaceuticals generic version of Astra’s Nexium ulcer capsules.
-
Thu 24 Dec 2009
Drug maker AstraZeneca said its biologics unit, Medimmune, has filed a Complete Response Letter (CRL) to the US Food and Drug Administration (FDA) in respect of its Biologics Licence Application (BLA) for motavizumab.
-
Wed 23 Dec 2009
AstraZeneca has done a deal to buy French private infection research company Novexel for as much as $505m (£316m).
-
Wed 16 Dec 2009
A US Food and Drug Administration (FDA) advisory committee has given a favourable verdict on the use of AstraZeneca’s anti-cholesterol drug Crestor.
-
Fri 04 Dec 2009
The US Food and Drug Administration (FDA) has approved the use of drug giant AstraZeneca’s bipolar disorder treatment Seroquel in conjunction with antidepressants to treat major depressive disorder (MDD).
-
Thu 03 Dec 2009
Anglo-Swedish drugs giant AstraZeneca is to licence TC-5214, the treatment for major depressive disorder (MDD) developed by biopharmaceutical company Targacept.
|
| |
|
|
|
|
Snapshot 